Hannah Yamagata

11PUBLICATIONS
44CO-AUTHORS
Haematological tumoursNanoscale characterisationNanometrologyCancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 08, 2026
mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.

|Apr 10, 2026
Resolving heterogeneity of targeted lipid nanoparticles through solution-based biophysical analyses.

Hannah C Geisler, Hannah C Safford, Ajay S Thatte

|Mar 24, 2026
Liver-Detargeted Aromatic Bioreducible mRNA Lipid Nanoparticles Confer Lymph Node Tropism and Robust Antigen-Specific Immunity.

Hannah M Yamagata, Marshall S Padilla, Alex G Hamilton

|Mar 19, 2026
Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy.

Qiangqiang Shi, Ningqiang Gong, Jinjin Wang

|Jan 22, 2026
Author Correction: Elucidating lipid nanoparticle properties and structure through biophysical analyses.

Marshall S Padilla, Sarah J Shepherd, Andrew R Hanna

|Dec 26, 2025
Automated and Parallelized Microfluidic Generation of Large and Precisely Defined Lipid Nanoparticle Libraries.

Andrew R Hanna, Sarah J Shepherd, Gregory A Datto

Pageof 2

Frequent Collaborators

10 joint publications

Michael J Mitchell

9 joint publications

Marshall S Padilla

5 joint publications

Kaitlin Mrksich

4 joint publications

Ryann A Joseph